As a college student during the 1970s, Lawrence Deyton grew a ponytail to the middle of his back. His mother “hated it, she just hated it,” he said.
So the young man, headed toward a career in public health, offered a trade.
GS Profiles
On call for global emergencies
Michelle Bernier-Toth’s State Dept. office responds to U.S. citizens’ global emergencies big and small.
One-time victim now leads fight against bullying
A bully in middle school set the course of Deborah Temkin’s life. Now she leads the federal government’s efforts to curb bullying.
Breaking the mother-child HIV link
Lynne Mofenson, a pediatrician at NIH, has spent her career studying mother-to-child HIV transmission.
Fed worker profiles: Scoville improves military amputees’ care
Scoville, 60, has been nominated for a federal award for his sports-based rehabilitation program .
Bringing calm after a disaster
Within the NTSB, Sharon Bryson helps families deal with their loss after fatal accidents. She is a finalist for the federal Service to America awards.
Award nominee heads FDA campaign against smoking
Lawrence Deyton, director of the Food and Drug Administration’s Center for Tobacco Products, is a candidate for a career service medal in what is considered the federal equivalent of the Academy Awards.
“Quit smoking, and I’ll cut my ponytail. She said, ‘Deal,’ ” recalled Deyton, sporting considerably less hair now. His mother quit the Pall Malls, and he mailed her the remains of his coiffure.
She lived 35 more years, said Deyton, director of the Food and Drug Administration’s Center for Tobacco Products. “In her effects, after she died, there was the ponytail.”
Deyton, 58, is a candidate for the federal government’s Career Achievement Medal, one of the nonprofit Partnership for Public Service’s Samuel J. Heyman Service to America Medals. The honors are known as the Academy Awards of government workers.
Deyton has spent his career trying to improve public health. Before working on tobacco, he was deeply involved in the campaign against AIDS as a leader of more than 200 National Institutes of Health-funded clinical trials of HIV therapies in the late 1980s and the 1990s. He diversified the participants in the trials, bringing in thousands of new patients.
“I cannot say how cutting-edge his approach was at the time,” Margaret A. Hamburg, the FDA commissioner, said in nominating Deyton for the award. “It brought research to communities that needed it. He understood the disconnect between patients and research, and he found a new way to do testing and develop products.”
In 1998, he became director of HIV/AIDS treatment programs at the Department of Veterans Affairs, at the time the nation’s largest provider of care for HIV-
infected patients. Four years later, he became director of a broader public health group within VA that oversaw programs aimed at hepatitis C, bioterrorism, possible flu pandemic and tobacco use, as well as HIV. He became VA’s chief health officer in 2006.
As the first employee of the FDA’s new Center for Tobacco Products, he leads the nationwide effort to reduce tobacco-related disease, which still causes 443,000 deaths each year, according to the Centers for Disease Control and Prevention. Smokers die, on average, 14 years earlier than nonsmokers.
“I have huge respect for smokers who are addicted, especially those trying to quit,” said Deyton, who has been at his current job for two years. “I don’t damn them. I don’t put them down. Nicotine is truly one of the most addictive products on the planet . . . as addictive as heroin and cocaine. So make no mistake: [Quitting] is not just a matter of will.”
Armed with a new law that gives the FDA the power to regulate the way tobacco is marketed, distributed and sold, the agency also requires that tobacco companies identify each of the 4,000-plus ingredients in cigarettes.
“I have said cigarettes, until now, are the only mass-consumed product in America that the consumer didn’t know what’s in it,” Deyton said. “We have a responsibility to understand what those products are and what it means to human health, and we are working on that now.”
Loading...
Comments